Time in the Therapeutic Range for Assessing Anticoagulation Quality in Patients Receiving Continuous Unfractionated Heparin

Due to variable pharmacokinetic properties, therapeutic anticoagulation with continuous unfractionated heparin (UFH) requires ongoing laboratory monitoring, generally with activated partial thromboplastin time (aPTT). In the ambulatory setting, clinicians who manage warfarin therapy often use time i...

Descripción completa

Detalles Bibliográficos
Autores principales: Ting, Clara, Sylvester, Katelyn W., Schurr, James W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714859/
https://www.ncbi.nlm.nih.gov/pubmed/30213200
http://dx.doi.org/10.1177/1076029618798944

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714859/
https://www.ncbi.nlm.nih.gov/pubmed/30213200
http://dx.doi.org/10.1177/1076029618798944

Ejemplares similares